RU95108457A - Method of treatment of severe forms of glps - Google Patents

Method of treatment of severe forms of glps

Info

Publication number
RU95108457A
RU95108457A RU95108457/14A RU95108457A RU95108457A RU 95108457 A RU95108457 A RU 95108457A RU 95108457/14 A RU95108457/14 A RU 95108457/14A RU 95108457 A RU95108457 A RU 95108457A RU 95108457 A RU95108457 A RU 95108457A
Authority
RU
Russia
Prior art keywords
treatment
autocryoplasma
glps
severe forms
nephrology
Prior art date
Application number
RU95108457/14A
Other languages
Russian (ru)
Other versions
RU2119356C1 (en
Inventor
М.И. Петричко
В.Л. Гатцук
Original Assignee
Хабаровский государственный медицинский институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хабаровский государственный медицинский институт filed Critical Хабаровский государственный медицинский институт
Priority to RU95108457A priority Critical patent/RU2119356C1/en
Publication of RU95108457A publication Critical patent/RU95108457A/en
Application granted granted Critical
Publication of RU2119356C1 publication Critical patent/RU2119356C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

FIELD: medicine, nephrology. SUBSTANCE: method involves additional carrying out plasmaphoresis in combination with autocryoplasma beginning from the second seance followed by recovery all autocryoplasma to patient. EFFECT: enhanced effectiveness of treatment at early disease stage, prevention of complications.

Claims (1)

Изобретение относится к нефрологии. С целью повышения качества лечения на ранних сроках заболевания и предупреждения осложнений предлагается дополнительно к дезинтоксикационной и заместительной терапии проводить плазмаферез, причем, начиная со второго сеанса, замещение проводить аутокриоплазмой, с последующим возвращением всей аутокриоплазмы больному.The invention relates to nephrology. In order to improve the quality of treatment in the early stages of the disease and prevent complications, it is proposed to carry out plasmapheresis in addition to detoxification and replacement therapy, and, starting from the second session, the replacement should be performed with autocryoplasma, followed by the return of all autocryoplasma to the patient.
RU95108457A 1995-05-24 1995-05-24 Method for treatment of series cases of hemorrhagic fever with nephrosis RU2119356C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95108457A RU2119356C1 (en) 1995-05-24 1995-05-24 Method for treatment of series cases of hemorrhagic fever with nephrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95108457A RU2119356C1 (en) 1995-05-24 1995-05-24 Method for treatment of series cases of hemorrhagic fever with nephrosis

Publications (2)

Publication Number Publication Date
RU95108457A true RU95108457A (en) 1997-02-27
RU2119356C1 RU2119356C1 (en) 1998-09-27

Family

ID=20168103

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95108457A RU2119356C1 (en) 1995-05-24 1995-05-24 Method for treatment of series cases of hemorrhagic fever with nephrosis

Country Status (1)

Country Link
RU (1) RU2119356C1 (en)

Also Published As

Publication number Publication date
RU2119356C1 (en) 1998-09-27

Similar Documents

Publication Publication Date Title
EA200400825A1 (en) METHODS OF DELAY IN AGING, AND ALSO TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH AGING
ATE241378T1 (en) COMBINATIONS OF VASOPRESSIN AND ADRENERGIC ACTIVES FOR THE TREATMENT OF SUDDEN CARDIAC DEATH
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
ES2164916T3 (en) TREATMENT OF MULTIPLE SCLEROSIS.
DE69834724D1 (en) Treatment of bowel or bladder infections
PT1237562E (en) PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
RU95108457A (en) Method of treatment of severe forms of glps
DE69906928D1 (en) FAT BINDING POLYMERE LIPASE HEMMER COMBINATIONS FOR THE TREATMENT OF GRAVITY
NO971453D0 (en) Use of bradykinin antagonists in the manufacture of drugs for the treatment of chronic fibrogenetic and acute liver diseases
EA199900006A1 (en) PREPARATION AND METHOD FOR THE TREATMENT OF STRONG HEART FAILURE
AU1601499A (en) Citicoline to treat motor neuron diseases and demyelinating diseases
RU2070058C1 (en) Method of chronic bronchitis treatment
SU1258413A1 (en) Method of treatment of psoriasis
EA004801B1 (en) Method of treating peyronie's disease
RU95100169A (en) Method of psychophysiological correction of alcohol addiction
RU96117517A (en) METHOD FOR TREATING DIABETIC RETINOPATHY
RU96117516A (en) METHOD FOR TREATING PRE- AND PROLIFERATIVE DIABETIC RETINOPATHY
MD1469G2 (en) Method of treatment of the burn shock
RU95107993A (en) Method for treating sepsis and pyoseptic complications
Arunachalarn et al. Efficacy of placentrex drug against corneal defects in Mecheri sheep
RU97115829A (en) METHOD FOR TREATING PERFORMANCE OF COLLUS IN CHILDREN
RU96114051A (en) METHOD FOR TREATING ECZEMA IN TRAUMATOLOGIC AND ORTHOPEDIC PATIENTS WITH PURULENT INFECTION
RU94037731A (en) Method for treating multiple sclerosis